Ranok is a clinical-stage biopharmaceutical company committed to creating transformative medicines for cancer and other serious diseases. The company's innovative approach, CHAMP®, is a targeted protein degradation technology that rapidly identifies and advances CHAMP® degraders for a variety of important disease targets. Ranok's R&D team brings deep biological insight and chemistry expertise to the development of novel therapeutics, with the goal of benefiting patients around the world. For more information, visit www.ranoktherapeutics.com or follow @RanokTx on LinkedIn and Twitter.